Product Code: ETC4538021 | Publication Date: Jul 2023 | Updated Date: Sep 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market is emerging as a significant segment within the broader functional food and nutraceutical industry. HMOs are complex carbohydrates naturally found in breast milk, and they offer various health benefits, including supporting the development of a healthy gut microbiome and enhancing the immune system. The increasing awareness of the importance of early-life nutrition and the role of HMOs in infant formula and dietary supplements has fueled market growth. The UAE rising birth rate and the government`s efforts to promote breastfeeding have further accelerated the demand for HMO-based products.
The UAE Human Milk Oligosaccharides (HMO) market is experiencing robust growth due to a combination of factors. Firstly, there is a growing awareness and understanding of the health benefits of HMOs, which are naturally occurring in human breast milk. These complex sugars have been found to play a crucial role in promoting infant gut health, strengthening the immune system, and providing other health advantages. As a result, there is an increasing demand for HMO-based infant formula and dietary supplements, especially in a country where infant nutrition is a significant concern. Secondly, the UAE thriving healthcare and research sectors are actively exploring HMOs` applications, further driving the market. Additionally, manufacturers in the UAE are investing in research and development to create innovative HMO products and cater to the rising demand, resulting in a significant market boost.
The HMO market faces complexities in replicating the natural composition of human milk, ensuring the safety and efficacy of synthetic HMOs, and meeting the growing demand for infant formula enriched with HMOs while complying with stringent regulations.
The Human Milk Oligosaccharides (HMO) market in the UAE experienced challenges during the COVID-19 pandemic, impacting the infant formula and functional food sector. Disruptions in manufacturing, regulatory considerations, and changing consumer preferences initially affected the HMO industry. The post-pandemic phase saw a resurgence in demand, with increased interest in HMO-enriched products for infant nutrition and gut health.
Key players in the UAE Human Milk Oligosaccharides (HMO) market include Jennewein Biotechnologie GmbH and Inbiose NV. Jennewein Biotechnologie GmbH, a global biotechnology company, has played a crucial role in supplying HMOs for various infant formula applications in the UAE. Inbiose NV, a biotech company specializing in the production of specialty carbohydrates, has also significantly contributed to the HMO market by offering innovative solutions for the food and nutrition industry in the UAE.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the health benefits of human milk oligosaccharides (HMOs) for infants |
4.2.2 Growing demand for organic and natural infant nutrition products in the UAE |
4.2.3 Rising disposable income and changing lifestyles leading to higher spending on premium infant formula products |
4.3 Market Restraints |
4.3.1 High production costs associated with extracting and synthesizing human milk oligosaccharides |
4.3.2 Limited availability of human milk sources for extraction of HMOs |
4.3.3 Stringent regulations and quality standards governing infant nutrition products in the UAE market |
5 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Trends |
6 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, By Types |
6.1 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 2?? Fl, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Fl, 2021-2031F |
6.1.5 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Sl, 2021-2031F |
6.1.6 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 6?? Sl, 2021-2031F |
6.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Infant Formula, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Functional Food & Beverages, 2021-2031F |
6.2.4 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Food Supplement, 2021-2031F |
6.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market, By Concentration |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Neutral, 2021-2031F |
6.3.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Acidic, 2021-2031F |
7 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Imports from Major Countries |
8 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Key Performance Indicators |
8.1 Research and development investment in HMO technology and innovation |
8.2 Adoption rate of HMO-enriched infant formula products by UAE consumers |
8.3 Number of partnerships and collaborations between HMO manufacturers and infant nutrition companies in the UAE |
9 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F |
10 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |